Trial Profile
Traumatic Brain Injury Recovery With n-3 Highly Unsaturated Fatty Acids (HUFAs): A Biomarker-driven Approach
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 14 Dec 2022
Price :
$35
*
At a glance
- Drugs Omega-3-acid ethyl esters (Primary)
- Indications Traumatic brain injuries
- Focus Biomarker; Pharmacodynamics
- 10 Oct 2022 Status changed from recruiting to withdrawn prior to enrolment.
- 18 Sep 2020 Planned End Date changed from 1 Dec 2021 to 1 Dec 2023.
- 18 Sep 2020 Planned primary completion date changed from 1 Jan 2021 to 1 Jan 2023.